4Rossini AA, Williams RM, Appel MC, et al. Sex difference in the multiple-dose streptozotocin model of diabetes [J]. Endocrinology,1978,103: 1518 - 1520.
5Anastasi E, Dotta F, Tiberti C, et al. Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose Stz mouse model of diabetes [ J ]. Autoimmunity, 1999, 29:249 -256.
6Bach JF. Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases[ J]. Arthritis Res, 2002, Suppl 3: S1 - S15.
7Shimada A, Charlton B, Taylor-Edwards C, et al. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetes mice[J]. Diabetes, 1996, 45(8): 1063 - 1067.
8Baeder WL, Sredy J, Sehgal SN, et al. Rapamycin prevents the onset of insulin dependent diabetes mellitus (IDDM) in NOD mice[J].Clin Exp Immunol, 1992,89:174 - 178.
9Nicoletti F, Di Marco R, Barcellini W, et al. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor [J]. Eur J Immunol, 1994, 24:1843 -1847.
10Hunger RE, Carnaud C, Garcia 1, et al. Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55 [J]. Eur J Immunol, 1997,27 (1):255 - 261.
